» Articles » PMID: 36499072

Mechanisms Involved in the Neurotoxicity and Abuse Liability of Nitrous Oxide: A Narrative Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Dec 11
PMID 36499072
Authors
Affiliations
Soon will be listed here.
Abstract

The recreational use of nitrous oxide (NO) has increased over the years. At the same time, more NO intoxications are presented to hospitals. The incidental use of NO is relatively harmless, but heavy, frequent and chronic use comes with considerable health risks. Most importantly, NO can inactivate the co-factor cobalamin, which, in turn, leads to paresthesia's, partial paralysis and generalized demyelinating polyneuropathy. In some patients, these disorders are irreversible. Several metabolic cascades have been identified by which NO can cause harmful effects. Because these effects mostly occur after prolonged use, it raises the question of whether NO has addictive properties, explaining its prolonged and frequent use at high dose. Several lines of evidence for NO's dependence liability can be found in the literature, but the underlying mechanism of action remains controversial. NO interacts with the opioid system, but NO also acts as an N-methyl-D-aspartate (NMDA) receptor antagonist, by which it can cause dopamine disinhibition. In this narrative review, we provide a detailed description of animal and human evidence for NO-induced abuse/dependence and for NO-induced neurotoxicity.

Citing Articles

First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report.

Taillefer de Laportaliere T, Redon M, Roussin A, Willemet E, Very E, Olivier J Drug Alcohol Rev. 2025; 44(3):908-912.

PMID: 39901315 PMC: 11886473. DOI: 10.1111/dar.14012.


Nitrous oxide exerts rewarding effect via regulating D1 receptor and BDNF pathway in ventral tegmental area-nucleus accumbens dopamine circuit.

Li W, Liu S, Yang S, Lin X, Zhang Z Transl Psychiatry. 2025; 15(1):34.

PMID: 39875366 PMC: 11775255. DOI: 10.1038/s41398-025-03257-y.


A fatal case of accidental asphyxia following nitrous oxide inhalation and alcohol consumption.

Liu H, Liang M, Yang Y, Ma J, Zhou Y, Dong H Forensic Sci Med Pathol. 2025; .

PMID: 39873889 DOI: 10.1007/s12024-025-00946-4.


Concurrence of Subacute Combined Degeneration and Deep Vein Thrombosis After Chronic Nitrous Oxide Abuse.

Seo J, Kim D, Joo I, Min J J Clin Neurol. 2025; 21(1):80-82.

PMID: 39778571 PMC: 11711264. DOI: 10.3988/jcn.2024.0319.


Nitrous Oxide Causing Subacute Combined Degeneration: A Case Report.

Thomas N, Patel R, Oluwadamilola B Cureus. 2025; 16(11):e74871.

PMID: 39741609 PMC: 11685159. DOI: 10.7759/cureus.74871.


References
1.
Swart G, Blair C, Lu Z, Yogendran S, Offord J, Sutherland E . Nitrous oxide-induced myeloneuropathy. Eur J Neurol. 2021; 28(12):3938-3944. DOI: 10.1111/ene.15077. View

2.
Wood R, Grubman J, Weiss B . Nitrous oxide self-administration by the squirrel monkey. J Pharmacol Exp Ther. 1977; 202(3):491-9. View

3.
Berkowitz B, Finck A, Hynes M, NGAI S . Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology. 1979; 51(4):309-12. DOI: 10.1097/00000542-197910000-00006. View

4.
van Amsterdam J, Nabben T, van den Brink W . Recreational nitrous oxide use: Prevalence and risks. Regul Toxicol Pharmacol. 2015; 73(3):790-6. DOI: 10.1016/j.yrtph.2015.10.017. View

5.
Tobias J . Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000; 28(6):2122-32. DOI: 10.1097/00003246-200006000-00079. View